Yamazaki Kosuke相关文献与解析，生知库 | 链接生命科学的每一步

Yamazaki Kosuke, Iguchi Tomohiro, Kanoh Yutaka, Takayasu Kazuto, Ngo Trinh Thi To, Onuki Ayaka, Kawaji Hideya, Oshima Shunji, Kanda Tomomasa, Masai Hisao, Sasanuma Hiroyuki

毒理研究

发表日期：2024

文献求助收藏

SOD1 gains pro-oxidant activity upon aberrant oligomerization: change in enzymatic activity by intramolecular disulfide bond cleavage

SOD1异常寡聚化后获得促氧化活性：分子内二硫键断裂导致酶活性改变

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-022-15701-w

Yamazaki, Kosuke; Tahara, Shinya; Ohyama, Takumi; Kuroi, Kunisato; Nakabayashi, Takakazu

SOD1

发表日期：2022

文献求助收藏

Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients: extended follow-up of JBCRG-cohort study 01

HER2阳性早期乳腺癌患者曲妥珠单抗治疗的疗效：JBCRG队列研究01的延长随访

期刊:Breast Cancer

影响因子:2.9

doi:10.1007/s12282-020-01057-4

Yamashiro, Hiroyasu; Iwata, Hiroji; Masuda, Norikazu; Yamamoto, Naohito; Nishimura, Reiki; Ohtani, Shoichiro; Sato, Nobuaki; Takahashi, Masato; Kamio, Takako; Yamazaki, Kosuke; Saito, Tsuyoshi; Kato, Makoto; Lee, Tecchuu; Kuroi, Katsumasa; Takano, Toshimi; Yasuno, Shinji; Morita, Satoshi; Ohno, Shinji; Toi, Masakazu

Overproduction of thrombopoietin by BRAFV600E-mutated mouse hepatocytes and contribution of thrombopoietin to hepatocarcinogenesis.

BRAFV600E突变小鼠肝细胞过度产生血小板生成素，血小板生成素对肝癌发生的作用

期刊:Cancer Science

影响因子:4.3

doi:10.1111/cas.14130

Tanaka Hiroki, Horioka Kie, Yamamoto Masahiro, Asari Masaru, Okuda Katsuhiro, Yamazaki Kosuke, Shimizu Keiko, Ogawa Katsuhiro

Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational Study

接受新辅助/辅助曲妥珠单抗联合多药化疗治疗的HER2阳性复发性乳腺癌患者再次接受曲妥珠单抗联合细胞毒性化疗的生存结局：一项日本多中心观察性研究

期刊:Breast Cancer-Basic and Clinical Research

影响因子:1.9

doi:10.1177/1178223418786243

Yamashiro, Hiroyasu; Sawaki, Masataka; Masuda, Norikazu; Okumura, Yasuhiro; Takano, Toshimi; Tokunaga, Eriko; Saito, Tsuyoshi; Sagara, Yasuaki; Yamazaki, Kosuke; Kawaguchi, Yoshihiro; Lee, Tecchuu; Ozaki, Shinji; Yamagami, Kazuhiko; Yamamoto, Naohito; Kuroi, Katsumasa; Suwa, Hirofumi; Ohtani, Shoichiro; Ito, Toshikazu; Yasuno, Shinji; Morita, Satoshi; Ohno, Shinji; Toi, Masakazu

Role of the BrafV637E mutation in hepatocarcinogenesis induced by treatment with diethylnitrosamine in neonatal B6C3F1 mice.

BrafV637E 突变在新生 B6C3F1 小鼠二乙基亚硝胺治疗诱导的肝癌发生中的作用

期刊:Molecular Carcinogenesis

影响因子:3.2

doi:10.1002/mc.22510

Yamamoto Masahiro, Tanaka Hiroki, Xin Bing, Nishikawa Yuji, Yamazaki Kosuke, Shimizu Keiko, Ogawa Katsuhiro

Strategies to improve the thermoelectric performance of iron silicide-based materials

提高硅化铁基材料热电性能的策略

Homologous recombination contributes to the repair of acetaldehyde-induced DNA damage.

同源重组有助于修复乙醛引起的DNA损伤

SOD1 gains pro-oxidant activity upon aberrant oligomerization: change in enzymatic activity by intramolecular disulfide bond cleavage

SOD1异常寡聚化后获得促氧化活性：分子内二硫键断裂导致酶活性改变

Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients: extended follow-up of JBCRG-cohort study 01

HER2阳性早期乳腺癌患者曲妥珠单抗治疗的疗效：JBCRG队列研究01的延长随访

Overproduction of thrombopoietin by BRAFV600E-mutated mouse hepatocytes and contribution of thrombopoietin to hepatocarcinogenesis.

BRAFV600E突变小鼠肝细胞过度产生血小板生成素，血小板生成素对肝癌发生的作用

Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational Study

接受新辅助/辅助曲妥珠单抗联合多药化疗治疗的HER2阳性复发性乳腺癌患者再次接受曲妥珠单抗联合细胞毒性化疗的生存结局：一项日本多中心观察性研究

Role of the BrafV637E mutation in hepatocarcinogenesis induced by treatment with diethylnitrosamine in neonatal B6C3F1 mice.

BrafV637E 突变在新生 B6C3F1 小鼠二乙基亚硝胺治疗诱导的肝癌发生中的作用